Funded Projects › FP7
ICRMYELOMA · Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma
Plasma cell myeloma (PCM) is an incurable malignancy. Cytogenetics, molecular genetics and single nucleotide polymorphism arrays have shown significant genetic complexity in PCM. However, these screens reflect only the predominant clonal population and genetic-based prognostic classification of PCM can predict the outcome only in a subset of cases. To better understand the oncogenesis of PCM combined investigation of genetic abnormalities at single cell level is needed.The original theory of clonal evolution in cancer proposed a stepwise, linear acquisition of mutations
Consortium · 1 organisation
INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
UK · €209,033
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.